The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALLERGAN PLC | SHS | G0177J108 | 171,432 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 53,000 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 66,987 | 1,620,000 | SH | SOLE | 1,620,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 105,993 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| BROOKDALE SENIOR LIVING | COM | 112463104 | 63,895 | 6,500,000 | SH | SOLE | 6,500,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 51,398 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 20,217 | 291,600 | SH | SOLE | 291,600 | 0 | 0 | ||
| ENDOLOGIX INC | COM | 29266S106 | 17,763 | 9,300,000 | SH | SOLE | 9,300,000 | 0 | 0 | ||
| ENVISION HEALTHCARE CORP | COM | 29414D100 | 61,964 | 1,355,000 | SH | SOLE | 1,355,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 78,850 | 2,075,000 | SH | SOLE | 2,075,000 | 0 | 0 | ||
| HCA HEALTHCARE INC | COM | 40412C101 | 139,120 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| K2M GROUP HLDGS INC | COM | 48273J107 | 27,370 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 99,488 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 59,820 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 75,715 | 2,878,890 | SH | SOLE | 2,878,890 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 137,250 | 3,750,000 | SH | SOLE | 3,750,000 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 91,440 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| PERRIGO CO PLC | SHS | G97822103 | 70,800 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 34,388 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 581,440 | 2,000,000 | SH | Put | SOLE | 2,000,000 | 0 | 0 | |
| SURGERY PARTNERS INC | COM | 86881A100 | 2,229 | 135,084 | SH | SOLE | 135,084 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 9,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| TENET HEALTHCARE CORP | COM NEW | 88033G407 | 44,113 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 136,535 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 115,056 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| ZYMEWORKS INC | COM | 98985W102 | 21,556 | 1,373,000 | SH | SOLE | 1,373,000 | 0 | 0 | ||